SuperworthTonix Pharmaceuticals market cap TNXP
Share price times shares outstanding: what the whole company sells for, since 2012.
- Today, Oct 23, 2026
- $88.7M
- Highest close in our data
- $2.9B
- Mar 2021
Tonix Pharmaceuticals is worth $88.7M at the close on Oct 23, 2026, at $5.17 a share.
That is down 48% over the last year and down 93% over five years.
Its highest close in our data was $2.9B in Mar 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $88.7M | $88.7M | $250.9M | −54% |
| 2025 | $191.5M | $14.7M | $450.1M | +203% |
| 2024 | $63.1M | $1.3M | $114.3M | +556% |
| 2023 | $9.6M | $9M | $467.5M | −93% |
| 2022 | $140.2M | $115.5M | $929.7M | −86% |
| 2021 | $982.8M | $820.1M | $2.9B | +49% |
| 2020 | $660.6M | $4.2M | $830.5M | +5975% |
| 2019 | $10.9M | $8.5M | $51.6M | +25% |
| 2018 | $8.7M | $8.7M | $40.6M | −69% |
| 2017 | $28.1M | $16.3M | $37.8M | +47% |
| 2016 | $19.2M | $11.9M | $65.2M | −74% |
| 2015 | $75.2M | $32.3M | $84.7M | +117% |
| 2014 | $34.7M | $13.2M | $42.1M | +156% |
| 2013 | $13.6M | $2.1M | $13.6M | +230% |
| 2012 | $4.1M | $4.1M | $13.9M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Tonix Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| TNXPTonix Pharmaceuticals | $88.7M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| ATNMActinium Pharmaceuticals | $47.8M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $523.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Tonix Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.